COMMUNIQUÉS West-GlobeNewswire

Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange
12/02/2019
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) (the “Company”) (TSXV: MDP, OTCQB: PDDPF) today announced that the 6.0% unsecured convertible debentures of the Company [...]
WW Schedules Fourth Quarter and Full Year 2018 Earnings Conference Call
12/02/2019
NEW YORK, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Weight Watchers International, Inc. (NASDAQ: WTW) (“WW”) will release its results for the fourth quarter and full year 2018 after market close on Tuesday, February 26, 2019. [...]
IRIDEX Announces Resolution of its Dispute with Quantel Medical
12/02/2019
MOUNTAIN VIEW, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced that it has resolved its differences with Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. ( [...]
Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada
12/02/2019
MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that CEO, Shital Mars will be the keynote speaker at Cold Chain [...]
BioSig Technologies Inc. Issues 2019 Shareholder Letter
12/02/2019
Company provides updates on recent developments and highlights plans for future growth Santa Monica, CA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors
12/02/2019
Provides Funding to Support Ongoing Activities Including Inventory Ramp, Plant Expansion, Product Launch and Plasma Collection Center Development RAMSEY, N.J. and BOCA RATON, Fla., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ADMA [...]
Loop Industries Completes and Expands Supply Agreement With Danone for 100% Sustainable PET
12/02/2019
MONTREAL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Loop Industries, Inc. (Nasdaq: Loop) (“Loop” or the “Company”), a leading technology innovator in sustainable plastic for packaging, today announced that it has completed a [...]
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 19 at 8:30 a.m. ET to Discuss 2018 Results and Recent Business Highlights
12/02/2019
PHILADELPHIA, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, will host a [...]
Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis
12/02/2019
SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced the completion of enrollment in ENCORE-LF, a Phase 2b clinical trial evaluating emricasan, the company’s first-in- [...]
Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal
12/02/2019
Canntab enters into 3-way supply agreement to purchase up to 1,000 kg of 2018 hemp crop TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab”), a leader in the [...]
Parkinson’s Disease: ProMIS Neurosciences Identifies Several Antibody Drug Candidates Showing Best-in-Class Selectivity for Toxic Forms of Alpha-Synuclein Compared to other Therapeutic Antibodies in Development
12/02/2019
Competitive Differentiation of ProMIS Antibodies is Key to Ongoing Partnering Discussions with Large Pharmaceutical Companies TORONTO and CAMBRIDGE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. ( [...]
Canada House Wellness Group Inc. Announces Full Operations in its Facility, Commences Full-Scale Production of EU-GMP Certified Cannabis
12/02/2019
Canada House is Positioned to Leverage its Newly Awarded Sales License and Will Have EU-GMP Certified Medical Grade Cannabis Ready for Patients by July 2019 TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Canada House [...]
Microbix Reports Results for Q1 Fiscal 2019
12/02/2019
Lower Sales, Improving Gross Margin, Positive Cash Flow from Operations TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix ® ), an innovator of biological products and technologies, [...]
Yuhan Corp and Sorrento Therapeutics Announce Closing of a $40m USD Financing for Joint Venture ImmuneOncia to Support Advancement of Immuno-Oncology Program
12/02/2019
SEOUL, South Korea and SAN DIEGO, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Yuhan Corporation (000100.KS; Yuhan) and Sorrento Therapeutics (Nasdaq: SRNE) announced today that ImmuneOncia, a joint venture formed in September [...]
Verrica Announces Late-Breaking Oral Presentation at the 2019 American Academy of Dermatology Annual Meeting
12/02/2019
Results from Two Pivotal Phase 3 Clinical Trials of Lead Candidate VP-102 in the Treatment of Molluscum Contagiosum to be Presented on March 2, 2019 WEST CHESTER, Pa., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Verrica [...]
Amicus Therapeutics to Announce Full-Year 2018 Financial Results on February 28, 2019
12/02/2019
CRANBURY, N.J., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, February 28, 2019 at 8:30 a.m. ET to [...]
Tetra Bio-Pharma Provides Update on its Neuropathic and Chronic Pain Drug Development Program
12/02/2019
ORLEANS, Ontario, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-derived drug development and discovery, [...]
BriaCell Appoints Jamieson Bondarenko to its Board of Directors
12/02/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (TSX-V:BCT) (OTCQB:BCTXF) (" BriaCell " or the " Company "), an immuno-oncology focused biotechnology [...]
Emergent BioSolutions Announces Appointment of Seamus Mulligan to its Board of Directors
12/02/2019
GAITHERSBURG, Md., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Seamus Mulligan to the company’s Board of Directors effective March 19, 2019. Mr. Mulligan [...]

Pages